Statin-based treatment for cardiovascular risk and non-alcoholic fatty liver disease. Killing two birds with one stone?

Author： Athyros Vasilios G.   Tziomalos Konstantinos   Daskalopoulos Georgios N.   Karagiannis Asterios   Mikhailidis Dimitri P.  

Publisher： Informa Healthcare

ISSN： 0785-3890

Source： Annals of Medicine, Vol.43, Iss.3, 2011-05, pp. : 167-171

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Non-alcoholic fatty liver disease

By Smith Briohny W.   Adams Leon A.  

Critical Reviews in Clinical Laboratory Sciences, Vol. 48, Iss. 3, 2011-06 ,pp. : 97-113

Informa Healthcare

Access to resources Recommend Favorite

Early life programming and the risk of non-alcoholic fatty liver disease

By  

Journal of Developmental Origins of Health and Disease, Vol. 8, Iss. 3, 2017-01 ,pp. : 263-272

Cambridge University Press

Access to resources Recommend Favorite

New diagnostic and treatment approaches in non-alcoholic fatty liver disease (NAFLD)

By Ali Rafeeq   Cusi Kenneth  

Annals of Medicine, Vol. 41, Iss. 4, 2009-01 ,pp. : 265-278

Informa Healthcare

Access to resources Recommend Favorite

Heterogeneity of non‐alcoholic fatty liver disease

By  

LIVER INTERNATIONAL (ELECTRONIC), Vol. 35, Iss. 12, 2015-12 ,pp. : 2498-2500

John Wiley & Sons Inc

Access to resources Recommend Favorite

Non-Alcoholic Fatty Liver Disease in Older People

By  

Gerontology, Vol. 55, Iss. 6, 2009-08 ,pp. : 607-613

Karger

Access to resources Recommend Favorite